You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CHIR258, CHIR-258, CHIR 258, TKI258, TKI-258, TKI 258,

Showing 51 - 75 of 631
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastrinoma, Glucagonoma, Insulinoma Trial (dovitinib lactate, pharmacological study, laboratory biomarker analysis)

Withdrawn
  • Gastrinoma
  • +5 more
  • dovitinib lactate
  • +2 more
  • (no location specified)
Jul 18, 2017

Dalpiciclib Combined With Third-generation EGFR-TKI in EGFR

Not yet recruiting
  • Non-small Cell Lung Cancer Confirmed by Histopathology or Cytology
  • +6 more
    • (no location specified)
    Aug 9, 2022

    One Anastomosis Gastric Bypass for Severe Obesity in 6,722

    Completed
    • Morbid Obesity
    • One Anastomosis Gastric Bypass
    • Tel Aviv, Israel
      Assuta Medical Center
    Jul 31, 2022

    Gastrointestinal Stromal Tumors Trial in Changsha (Apatinib Mesylate, Sunitinib, Imatinib dosage, Dasatinib, Reveratinib)

    Recruiting
    • Gastrointestinal Stromal Tumors
    • Apatinib Mesylate
    • Sunitinib, Imatinib dosage, Dasatinib, Reveratinib
    • Changsha, Hunan, China
      Xiangya Hospital, Central South University
    Mar 1, 2023

    Stage IIIA Hepatocellular Carcinoma Trial (Radiotherapy combined with TKI and Anti-PD-1 Antibody)

    Not yet recruiting
    • Stage IIIA Hepatocellular Carcinoma
    • Radiotherapy combined with TKI and Anti-PD-1 Antibody
    • (no location specified)
    Sep 24, 2023

    Non-proliferative Diabetic Retinopathy Trial (OTX-TKI, Sham)

    Not yet recruiting
    • Non-proliferative Diabetic Retinopathy
    • (no location specified)
    Jan 12, 2023

    Patients Who Received EGFR-TKI for the Treatment of NSCLC and Developed Paronychia (Affecting Fingernails, Toenails or Both)

    Recruiting
    • Patients Who Received EGFR-TKI for the Treatment of Non-small Cell Lung Cancer and Developed Paronychia (Affecting Fingernails, Toenails or Both)
    • Topical Timolol
    • Hong Kong, Hong Kong
      Queen Mary Hospital
    Nov 14, 2023

    HER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy Trial (Trastuzumab Emtansine for Injection, Pyrotinib Maleate

    Not yet recruiting
    • HER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy
    • Trastuzumab Emtansine for Injection
    • Pyrotinib Maleate Tablets
    • (no location specified)
    Sep 30, 2022

    Chronic Myelogenous Leukemia Trial in Houston (TGRX-678)

    Not yet recruiting
    • Chronic Myelogenous Leukemia
    • Houston, Texas
      The University of Texas MD Anderson Cancer Center
    Oct 12, 2023

    HRQOL in Locally Advanced Thyroid Carcinoma

    Recruiting
    • Thyroid Cancer
    • +2 more
    • Tyrosine kinase inhibitor drugs.
    • Fuzhou, Fujian, China
      Road Fuma No.420
    Apr 11, 2023

    Tumors, Kidney Tumors, Urologic Tumors Trial in Nanjing (Toripalimab, Axitinib, Lenvatinib)

    Recruiting
    • Neoplasms
    • +12 more
    • Nanjing, Jiangsu, China
      Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
    Oct 28, 2023

    Acute Lymphoblastic Leukemia Trial in Ann Arbor (Dasatinib, Ponatinib, Berlin-Frankfurt-Münster Chemotherapy)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • Ann Arbor, Michigan
      University of Michigan Rogel Cancer Center
    Nov 28, 2022

    NSCLC Trial in Shanghai (IN10018, Furmonertinib)

    Recruiting
    • NSCLC
    • Shanghai, China
      Shanghai Pulmonary Hospital
    Aug 8, 2023

    NSCLC With EGFR Mutation Trial in Mexico City (Glutamine plus L. reuteri)

    Recruiting
    • Non-Small Cell Lung Cancer With EGFR Mutation
    • Glutamine plus L. reuteri
    • Mexico City, Mexico
      Instituto Nacional de Cancerologia de Mexico
    May 2, 2023

    NSCLC Trial (SKB264, Pemetrexed, Carboplatin)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • (no location specified)
    May 23, 2023

    Anlotinib Treatment Response Using Contrast Enhanced Ultrasound

    Recruiting
    • Pheochromocytoma, Metastatic
    • +3 more
    • Contrast-enhanced ultrasound(CEUS)
    • Beijing, China
      Peking Union Medical College Hospital
    Aug 28, 2023

    Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)

    Not yet recruiting
    • Tyrosine Kinase Inhibitors
    • Chronic Myeloid Leukemia
    • treatment of TKI in CML
    • Poitiers, France
      Chu Poitiers
    Feb 21, 2023

    Renal Cell Carcinoma Trial in Worldwide (Nivolumab, Bempegaldesleukin, Axitinib)

    Active, not recruiting
    • Renal Cell Carcinoma
    • Nivolumab
    • +2 more
    • Springdale, Arkansas
    • +33 more
    Nov 22, 2022

    Liver Tumors Trial in Beijing (Tislelizumab plus tyrosine kinase inhibitor)

    Recruiting
    • Liver Neoplasms
    • Tislelizumab plus tyrosine kinase inhibitor
    • Beijing, Beijing, China
      302 Hospital
    Sep 22, 2023

    Effectiveness, Sexuality Trial in Zhengzhou (Lenvatinib mesylate capsule)

    Not yet recruiting
    • Effectiveness
    • Sexuality
    • Lenvatinib mesylate capsule
    • Zhengzhou, Henan, China
      Department of Bone and Soft Tissue ,Henan Cancer Hospital
    Jan 31, 2023

    Carcinoma, Non-Small Cell Lung, EGFR Gene Mutation Trial in Changsha (Gemcitabine platinum combined with erlotinib)

    Recruiting
    • Carcinoma, Non-Small Cell Lung
    • EGFR Gene Mutation
    • Gemcitabine platinum combined with erlotinib
    • Changsha, Hunan, China
      Hunan Province Tumor Hospital
    Feb 28, 2022

    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia Trial in Philadelphia (Text

    Recruiting
    • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • Chronic Phase Chronic Myelogenous Leukemia
    • Text Message-Based Navigation Intervention
    • Survey Administration
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Apr 7, 2022

    Non-small-cell Lung Carcinoma Trial in Beijing (SY-3505)

    Recruiting
    • Non-small-cell Lung Carcinoma
    • Beijing, China
      Cancer Hospital, Chinese Academy of Medical Sciences
    May 11, 2023

    Chronic Myeloid Leukemia Trial in Saint-Étienne (Pharmaceutical intervention)

    Recruiting
    • Chronic Myeloid Leukemia
    • Pharmaceutical intervention
    • Saint-Étienne, France
      CHU de Saint-Etienne
    Feb 24, 2022

    Oligometastatic Disease, NSCLC, Driver Mutation Trial in Mumbai (Local Consolidative Radiation Therapy, TKI)

    Recruiting
    • Oligometastatic Disease
    • +2 more
    • Local Consolidative Radiation Therapy
    • TKI
    • Mumbai, Maharashtra, India
      Tata Memorial Hospital
    Mar 11, 2022